Literature DB >> 23282449

Subgroups of patients with Crohn's disease have different clinical outcomes.

F Perri1, V Annese, G Napolitano, N Caruso, R Clemente, M R Villani, A Andriulli.   

Abstract

: Eighty-three patients with long-standing Crohn's disease (CD) were retrospectively reviewed to determine whether natural history and clinical outcome were different and a patient subgroup classification could be reliably adopted. In all patients, the initial anatomical location, the "behavioral pattern," and the operative history of the disease were evaluated. Two different patterns of disease emerged: the first was characterized by a primarily fistulizing or fibrostenotic "behavior" with severe clinical disease and early requirement for surgery; the second was characterized by a primarily inflammatory "behavior" with a less severe disease and less need for surgery. No correlation of these patterns with gender, age at diagnosis, disease duration, smoking habit, and presence of extraintestinal manifestations could be found. The only other factor significantly related to the clinical course of disease was the anatomical location. The occurrence of two distinct CD patient subgroups with different clinical course and prognosis may have important implications in planning prospective trials and adequate therapeutic strategies.

Entities:  

Year:  1996        PMID: 23282449

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  2 in total

1.  Clinical subtypes of Crohn's disease according to surgical outcome.

Authors:  S E Greenway; M A Buckmire; C Marroquin; L Jadon; R H Rolandelli
Journal:  J Gastrointest Surg       Date:  1999 Mar-Apr       Impact factor: 3.267

2.  Crohn's Disease Localization Displays Different Predisposing Genetic Variants.

Authors:  Orazio Palmieri; Fabrizio Bossa; Maria Rosa Valvano; Giuseppe Corritore; Tiziana Latiano; Giuseppina Martino; Renata D'Incà; Salvatore Cucchiara; Maria Pastore; Mario D'Altilia; Daniela Scimeca; Giuseppe Biscaglia; Angelo Andriulli; Anna Latiano
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.